EZH2 and colorectal carcinoma: These data indicated that the expression levels of EZH2 and GLS changed dramatically due to different locations in tumor tissues, which explained why the RNA sequencing data did not show a good correlation between EZH2 and GLS expression in CRC (Fig. 4A–C).